Pegloticase treatment (8 mg every 2 weeks) was also associated with higher rates of complete ... The utility of DECT was assessed in 20 patients with tophaceous gout and 10 control participants with ...
The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...
Hammertoes are sometimes the result of neurological disorders such as neuropathy and stroke. Hammertoes may also affect balance and posture. The big toe is a favorite spot for the development of gout, ...